Back to Journals » OncoTargets and Therapy » Volume 10

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Authors Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH

Received 9 May 2016

Accepted for publication 26 August 2016

Published 22 December 2016 Volume 2017:10 Pages 137—144


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Manfred Beleut

Peer reviewer comments 3

Editor who approved publication: Dr Faris Farassati

Tae Won Kwak,1,* Su Bum Park,2,* Hyun-Jung Kim,3 Young-IL Jeong,4 Dae Hwan Kang1,2

1Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, 2Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Gyeongnam, 3Genewel Co. Ltd. Seongnam, Gyeonggi-do, 4Biomedical Research Institute, Pusan National University Hospital, Pusan, Republic of Korea

*These authors equally contributed to this work

Purpose: Epigallocatechin-3-gallate (EGCG) is an antioxidant agent derived from green tea. Because it has chemopreventive and anti-invasive effect against various cancer cells, EGCG can be used to inhibit proliferation and invasion of cholangiocarcinoma (CCA) cells.
Methods: The anticancer effects of EGCG were studied using human CCA cells (HuCC-T1). Apoptosis was analyzed by Western blotting. Invasion and migration of cancer cells were assessed with Matrigel® and wound healing assays. An animal tumor xenograft model of HuCC-T1 was used to study the in vivo antitumor activities of EGCG.
Results: EGCG effectively inhibited the growth of HuCC-T1 cells with no adverse effects on the viability of 293T cells. EGCG induced apoptotic cell death at 5 µg/mL concentration. It inhibited the expression of mutant p53 and induced apoptotic molecular signals such as Bax/Bcl-2, Caspase, and cytochrome C. Furthermore, EGCG dose-dependently inhibited the activity of matrix metalloproteinase (MMP)-2/9, invasion, and migration. In the animal tumor xenograft model of HuCC-T1 cells, EGCG was subcutaneously administered beside the tumor for local treatment. EGCG efficiently inhibited growth of the tumor and suppressed carcinogenic molecular signals such as Notch1, MMP-2/9, and proliferating cell nuclear antigen.
Conclusion: EGCG induced apoptosis of cancer cells without adverse effects on normal cells. EGCG inhibited growth, invasion, and migration of HuCC-T1 cells. We suggest EGCG as a promising candidate for local treatment of CCA.

Keywords: epigallocatechin-3-gallate, cholangiocarcinoma, matrix metalloproteinases-2, invasion, thermosensitive hydrogel

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]